The Medical Toxicology Foundation Presents Opioid Overdose Treatment Education for Emergency Physicians in Philadelphia

Share Article

With support from the Independence Blue Cross Foundation, the MTF hosts presentations in Philadelphia to educate physicians on administration of buprenorphine in the emergency department (ED) for opioid overdose patients.

We believe that offering patients a treatment opportunity during their ED visit destigmatizes medication use for recovery and demonstrates compassion and care to a highly at risk population.

With generous support from the Independence Blue Cross Foundation under the Supporting Treatment and Overdose Prevention (STOP) program, the Medical Toxicology Foundation presents ‘Curbing the Opioid Crisis in Philadelphia: Increasing Emergency Department Initiation of Buprenorphine-Naloxone for Opioid Use Disorder’ in part as a response to spiking overdose deaths in Philadelphia.

This one-hour presentation, designed to educate attending physicians and medical residents on administration of buprenorphine in the emergency department (ED) for opioid overdose patients, will be offered several times throughout 2019. Buprenorphine is “One of three medications approved in the United States to treat opioid addiction, it works by easing withdrawal symptoms and cravings” Goodnough, A. (2018, August 18) This E.R. Treats Opioid Addiction on Demand. That’s Very Rare.

Principal investigator, Jeanmarie Perrone, MD, FACMT, a professor of emergency medicine based at the Hospital of the University of Pennsylvania, along with co-faculty on this project, aim to demystify buprenorphine administration and to share the evidence for the efficacy of buprenorphine in the treatment of opioid use disorder. “This treatment, when initiated in the ED, doubles the rate of engagement in treatment at 30 days compared to patients given an outpatient referral for treatment. We believe that offering patients a treatment opportunity during their ED visit, destigmatizes medication use for recovery and demonstrates compassion and care to a highly at risk population,” explains Dr. Perrone.

Learn more at: https://www.acmt.net/mtf/Buprenorphine101.html

The Medical Toxicology Foundation (MTF) is the charitable arm of the American College of Medical Toxicology (ACMT), a nonprofit professional membership association. The mission of MTF is ‘Advancing research and education in the prevention and treatment of patients adversely impacted by drugs, chemicals and natural toxins.’ The MTF supports medical toxicologists through funding for research, travel awards and education.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Visit website

Media